{"disease":{"id":"skin-toxicity","name":"skin toxicity"},"drugs":{"marketed":[],"pipeline":[{"drug_id":"phytonadione","indication_name":"Skin toxicity from EGFR inhibitors","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT05109858","title":"Skin Toxicity by Oncological Therapies","phase":"","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","has_results":false},{"nct_id":"NCT07337486","title":"\"Evaluation of a Non-Pharmacological Skin Care Intervention for the Prevention and Treatment of Skin Toxicities Caused by Immunotherapy in Cancer Patients\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT04929847","title":"Novel Skin Care for Chemotherapy- Related Dermatologic Toxicities","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Jessa Hospital","has_results":false},{"nct_id":"NCT04305145","title":"Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04650256","title":"Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT03448731","title":"Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Fundacion CRIS de Investigación para Vencer el Cáncer","has_results":false},{"nct_id":"NCT06118047","title":"Crisaborole Ointment for Skin Toxicity Induced by Cetuximab","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":33,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03167268","title":"Panitumumab Skin Toxicity Prevention Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"Ospedale San Carlo Borromeo","has_results":false},{"nct_id":"NCT01317433","title":"Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT04523961","title":"Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Mayo Clinic","has_results":true}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}